减肥药市场规模预计将从 2021 年的 11.3255 亿美元增长到 2028 年的 22.7094 亿美元;预计 2021 年至 2028 年的复合年增长率为 10.4%。
减肥药是配合良好的饮食和锻炼习惯服用的药片,可帮助人们减肥。有多种选择,但 NHS 认为其中大多数都无效。一些减肥药可能对帮助人们减肥毫无用处,而其他一些减肥药可能有效但服用起来太危险。含有芬特明和托吡酯的减肥药已被证明可以帮助人们减肥。自我护理的增加、肥胖问题的加剧、老年人口的增加以及服用膳食补充剂的女性人数的激增也有望促进减肥药市场规模的增长。
减肥药市场根据产品类型、应用、年龄组、分销渠道和地理位置进行细分。按地理位置划分,市场大致分为北美、欧洲、亚太地区、中东和非洲以及南美和中美洲。减肥药市场报告提供了对市场的见解和深入分析,强调了市场趋势、技术进步、市场动态以及全球领先市场参与者的竞争分析。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
市场洞察
市场参与者推出新产品推动减肥药市场
就现代医疗保健而言,肥胖是全球面临的一大问题。肥胖可能导致其他几种相关的慢性疾病,如糖尿病和心血管疾病,这些是主要问题。使用特定的处方药和非处方药可能有助于有效控制体重的个人。这些药物以多种方式帮助有效控制体重。其中一些减肥药可能会阻止脂肪吸收并抑制食欲,从而帮助控制体重。因此,肥胖患病率的提高和对肥胖的担忧预计将在预测期内支持减肥药市场的增长。
以下是一些推出新型减肥药和新研发成果的公司的例子:
- 2022 年 2 月,Iovate Health Sciences International Inc. 旗下全国知名的 Hydroxycut 减肥补充剂品牌宣布了一项新的美国全国品牌活动,即“不追逐时尚,只为减肥”。该活动旨在强调三步减肥之旅。
- 2020 年 2 月,VIVUS LLC 和韩国营销合作伙伴 Alvogen 在韩国推出了 Qsymia(苯丁胺和托吡酯缓释片)。VIVUS LLC 与韩国减肥市场公认的领导者 Alvogen 签署了一项协议,以高效且经济的方式最大化商业阶段资产的价值。
市场参与者的此类发展正在推动减肥药市场的发展。
产品类型洞察
根据产品类型,全球减肥药市场分为处方药、非处方药和草药补充剂。2021 年,处方药占据了最大的市场份额。然而,草药补充剂领域预计将在 2021-2028 年期间实现最高的复合年增长率。人们对天然产品和预防性医疗保健的兴趣日益浓厚,以及健康和保健支出的激增是草药补充剂领域增长的主要驱动力。
应用程序洞察
根据应用,全球减肥药市场分为食欲抑制药、脂肪阻断药、代谢促进药等。2021 年,食欲抑制药占据了最大的市场份额;预计在 2021-2028 年期间,该药的复合年增长率最高。食欲抑制补充剂不含咖啡因或其他兴奋剂;但是,它可以增加能量和注意力。人们更有可能坚持锻炼习惯,并以更多的精力保持健康的生活方式。因此,这些原因可能会在预测期内促进该细分市场的增长。
产品发布和合作是全球减肥药市场参与者广泛采用的策略。以下列出了一些近期的关键市场发展:
- 2021 年 12 月,辉瑞公司以约 67 亿美元收购了 Arena Pharmaceuticals,以重塑其炎症药物组合。此外,辉瑞还拥有收购更多资产的独特优势。
- 2019 年 9 月,Currax Pharmaceuticals LLC 收购了 Nalpropion Pharmaceuticals, Inc. 此次收购后,Currax 拥有了 CONTRAVE 的全球权利,CONTRAVE 是美国排名第一的减肥处方品牌药物。
2020 年初,从事减肥药市场的公司由于实验室暂时关闭而受到不利影响。然而,在解除封锁后,全球的研究实验室重新开放。因此,许多服务提供商在 COVID-19 大流行期间优先考虑消费者的一些关键行动,例如提供一系列高质量的 COVID-19 相关研究工具;重新分配研发资源以生产必需产品;扩大供应链;支持对 COVID-19 相关研究产品的需求增加;并在英国、美国和中国开展讨论和合作,重点是 SARS-CoV-2 诊断、药物和疫苗开发。此外,在 COVID-19 疫情爆发后,免疫健康膳食补充剂的销量增加。许多人希望这些产品可以保护消费者免受 SARS-CoV-2 感染并降低 COVID-19 患者的病情严重程度。
然而,封锁扰乱了产品供应链,并导致原材料收集出现问题,因此对市场的影响微乎其微。这场疫情正在影响该地区各主要参与者的运营
减肥药市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响减肥药市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的减肥药市场细分和地理位置。
- 获取减肥药市场的区域特定数据
减肥药市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 11.3亿美元 |
2028 年市场规模 | 22.7 亿美元 |
全球复合年增长率(2021 - 2028) | 10.4% |
史料 | 2019-2020 |
预测期 | 2022-2028 |
涵盖的领域 | 按产品类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
减肥药市场参与者密度:了解其对业务动态的影响
减肥药市场正在快速增长,这得益于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素导致的终端用户需求不断增加。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在减肥药市场运营的主要公司有:
- 诺和诺德公司
- 盖莱西斯
- 维维斯有限责任公司
- 张氏保健
- 葛兰素史克公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解减肥药市场的主要参与者概况
减肥药市场细分
全球减肥药市场根据产品类型、应用、年龄组、分销渠道和地理位置进行细分。根据产品类型,市场分为处方药、非处方药和草药补充剂。根据应用,减肥药市场分为食欲抑制药、脂肪阻断药、代谢促进药和其他药。根据年龄范围,减肥药市场分为青少年和成年人。根据分销渠道,减肥药市场分为医院药房、网上药店、零售药店和药店。根据地理位置,减肥药市场分为北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲。
公司简介
- 诺和诺德公司
- 盖莱西斯
- 维维斯有限责任公司
- 张氏保健
- 葛兰素史克公司
- 辉瑞公司 (Arena Pharmaceutical GmbH)
- Iovate 健康科学国际公司
- Zoller 实验室
- Currax Pharmaceuticals LLC。
- 梯瓦制药工业有限公司
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global diet pills market on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and the South & Central America. In 2021, North American region held largest market share. However, Asia Pacific region is estimated to grow at the fastest CAGR of 11.0% during the forecast period
The global diet pills market based on product type, is segmented into prescription, over the counter drugs, and herbal supplements. In 2021, prescription segment held largest market share. However, herbal supplements segment is estimated to grow at the fastest CAGR of 10.9% during the forecast period.
The diet pills market majorly consists of the players such as Novo Nordisk A/S, Gelesis, VIVUS LLC, Chong's Health Care, GlaxoSmithKline plc., Pfizer Inc. (Arena Pharmaceutical GmbH), Iovate Health Sciences International Inc., Zoller Laboratories, Currax Pharmaceuticals LLC., TEVA PHARMACEUTICAL INDUSTRIES LTD.
The challenging regulatory environment is expected to restrict the market growth during the forecast period
Factors such as the increase in self-directed care, rising problem of obesity, and increase in elderly population & surge in women taking dietary supplements are driving the market. However, the challenging regulatory environment is expected to restrict the market growth during the forecast period.
Diet pills are tablets that are used in conjunction with a good diet and exercise routine to help people lose weight. There are a variety of options, but the NHS considers most of them ineffective. Some diet pills may be useless in helping people lose weight, while others may be effective yet too dangerous to use. Phentermine and topiramate-containing weight loss tablets have been proved to help people lose weight.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List Of Companies - Diet Pills Market
- Novo Nordisk A/S
- Gelesis
- VIVUS LLC
- Chong's Health Care
- GlaxoSmithKline plc.
- Pfizer Inc. (Arena Pharmaceutical GmbH)
- Iovate Health Sciences International Inc.
- Zoller Laboratories
- Currax Pharmaceuticals LLC.
- TEVA PHARMACEUTICAL INDUSTRIES LTD
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.